Status:
COMPLETED
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea
Lead Sponsor:
Nobelpharma
Conditions:
Dysmenorrhea
Eligibility:
FEMALE
16+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether combination oral contraceptive pill of norethindrone and ethinyl estradiol is effective in the treatment of primary dysmenorrhea.
Eligibility Criteria
Inclusion
- primary dysmenorrhea
Exclusion
- severe hepatopathy
- pregnant woman
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT00746096
Start Date
September 1 2008
End Date
September 1 2009
Last Update
March 6 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.